225 related articles for article (PubMed ID: 32111528)
1. Field challenges to measles elimination in the Democratic Republic of the Congo.
Coulborn RM; Nackers F; Bachy C; Porten K; Vochten H; Ndele E; Van Herp M; Bibala-Faray E; Cohuet S; Panunzi I
Vaccine; 2020 Mar; 38(13):2800-2807. PubMed ID: 32111528
[TBL] [Abstract][Full Text] [Related]
2. Predictors of measles vaccination coverage among children 6-59 months of age in the Democratic Republic of the Congo.
Ashbaugh HR; Hoff NA; Doshi RH; Alfonso VH; Gadoth A; Mukadi P; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Gerber SK; Cherry JD; Rimoin AW
Vaccine; 2018 Jan; 36(4):587-593. PubMed ID: 29248265
[TBL] [Abstract][Full Text] [Related]
3. Measles seroprevalence after reactive vaccination campaigns during the 2015 measles outbreak in four health zones of the former Katanga Province, Democratic Republic of Congo.
Keating P; Carrion Martin AI; Blake A; Lechevalier P; Uzzeni F; Gignoux E; Okonta C; Langendorf C; Smit S; Ahuka S; Suchard M; Pukuta E; Degail MA; Hansen L; Kibanza-Kyungu J; Ciglenecki I; Cohuet S
BMC Public Health; 2019 Aug; 19(1):1153. PubMed ID: 31438898
[TBL] [Abstract][Full Text] [Related]
4. Field evaluation of measles vaccine effectiveness among children in the Democratic Republic of Congo.
Doshi RH; Mukadi P; Shidi C; Mulumba A; Hoff NA; Gerber S; Okitolonda-Wemakoy E; Ilunga BK; Muyembe JJ; Rimoin AW
Vaccine; 2015 Jun; 33(29):3407-14. PubMed ID: 25937449
[TBL] [Abstract][Full Text] [Related]
5. The effect of immunization on measles incidence in the Democratic Republic of Congo: Results from a model of surveillance data.
Doshi RH; Shidi C; Mulumba A; Eckhoff P; Nguyen C; Hoff NA; Gerber S; Okitolonda E; Ilunga BK; Rimoin AW
Vaccine; 2015 Nov; 33(48):6786-92. PubMed ID: 26476363
[TBL] [Abstract][Full Text] [Related]
6. Measles in Democratic Republic of Congo: an outbreak description from Katanga, 2010-2011.
Grout L; Minetti A; Hurtado N; François G; Fermon F; Chatelain A; Harczi G; Ngoie Jde D; N'Goran A; Luquero FJ; Grais RF; Porten K
BMC Infect Dis; 2013 May; 13():232. PubMed ID: 23697535
[TBL] [Abstract][Full Text] [Related]
7. Measles antibody levels among vaccinated and unvaccinated children 6-59 months of age in the Democratic Republic of the Congo, 2013-2014.
Ashbaugh HR; Cherry JD; Hoff NA; Doshi RH; Alfonso VH; Gadoth A; Mukadi P; Higgins SG; Budd R; Randall C; Mwamba GN; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Gerber SK; Rimoin AW
Vaccine; 2020 Feb; 38(9):2258-2265. PubMed ID: 32057333
[TBL] [Abstract][Full Text] [Related]
8. Who gets vaccinated in a measles-rubella campaign in Nepal?: results from a post-campaign coverage survey.
Danovaro-Holliday MC; Rhoda DA; Lacoul M; Prier ML; Gautam JS; Pokhrel TN; Dixit SM; Rajbhandari RM; Bose AS
BMC Public Health; 2022 Feb; 22(1):221. PubMed ID: 35114969
[TBL] [Abstract][Full Text] [Related]
9. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
Newtonraj A; Vincent A; Selvaraj K; Manikandan M
Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
[TBL] [Abstract][Full Text] [Related]
10. Antecedent causes of a measles resurgence in the Democratic Republic of the Congo.
Scobie HM; Ilunga BK; Mulumba A; Shidi C; Coulibaly T; Obama R; Tamfum JJ; Simbu EP; Smit SB; Masresha B; Perry RT; Alleman MM; Kretsinger K; Goodson J
Pan Afr Med J; 2015; 21():30. PubMed ID: 26401224
[TBL] [Abstract][Full Text] [Related]
11. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of nationwide supplementary immunization in Lao People's Democratic Republic: Population-based seroprevalence survey of anti-measles and anti-rubella IgG in children and adults, mathematical modelling and a stability testing of the vaccine.
Hachiya M; Miyano S; Mori Y; Vynnycky E; Keungsaneth P; Vongphrachanh P; Xeuatvongsa A; Sisouk T; Som-Oulay V; Khamphaphongphane B; Sengkeopaseuth B; Pathammavong C; Phounphenghak K; Kitamura T; Takeda M; Komase K
PLoS One; 2018; 13(3):e0194931. PubMed ID: 29596472
[TBL] [Abstract][Full Text] [Related]
13. Proportion of children aged 9-59 months reached by the 2017 measles supplementary immunization activity among the children with or without history of measles vaccination in Lilongwe district, Malawi.
Kainga HW; Ssendagire S; Ssanyu JN; Nabukeera S; Namuhani N; Mangen FW
PLoS One; 2021; 16(1):e0243137. PubMed ID: 33428640
[TBL] [Abstract][Full Text] [Related]
14. Individual- and community-level determinants of child immunization in the Democratic Republic of Congo: A multilevel analysis.
Acharya P; Kismul H; Mapatano MA; Hatløy A
PLoS One; 2018; 13(8):e0202742. PubMed ID: 30138459
[TBL] [Abstract][Full Text] [Related]
15. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
Tohme RA; François J; Wannemuehler K; Magloire R; Danovaro-Holliday MC; Flannery B; Cavallaro KF; Fitter DL; Purcell N; Dismer A; Tappero JW; Vertefeuille JF; Hyde TB
Trop Med Int Health; 2014 Sep; 19(9):1105-15. PubMed ID: 25041586
[TBL] [Abstract][Full Text] [Related]
16. Measles control in Kinshasa, Zaire improved with high coverage and use of medium titre Edmonston Zagreb vaccine at age 6 months.
Cutts FT; Othepa O; Vernon AA; Nyandu B; Markowitz LE; Deforest A; Wilkins K; Okwo B
Int J Epidemiol; 1994 Jun; 23(3):624-31. PubMed ID: 7960392
[TBL] [Abstract][Full Text] [Related]
17. Impact of measles supplementary immunization activities on reaching children missed by routine programs.
Portnoy A; Jit M; Helleringer S; Verguet S
Vaccine; 2018 Jan; 36(1):170-178. PubMed ID: 29174680
[TBL] [Abstract][Full Text] [Related]
18. Determinants of low measles vaccination coverage in children living in an endemic area.
Lo Vecchio A; Cambriglia MD; Fedele MC; Basile FW; Chiatto F; Miraglia Del Giudice M; Guarino A
Eur J Pediatr; 2019 Feb; 178(2):243-251. PubMed ID: 30430239
[TBL] [Abstract][Full Text] [Related]
19. Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries.
Portnoy A; Jit M; Helleringer S; Verguet S
Value Health; 2020 Jul; 23(7):891-897. PubMed ID: 32762991
[TBL] [Abstract][Full Text] [Related]
20. Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20.
Prosperi C; Thangaraj JWV; Hasan AZ; Kumar MS; Truelove S; Kumar VS; Winter AK; Bansal AK; Chauhan SL; Grover GS; Jain AK; Kulkarni RN; Sharma SK; Soman B; Chaaithanya IK; Kharwal S; Mishra SK; Salvi NR; Sharma NP; Sharma S; Varghese A; Sabarinathan R; Duraiswamy A; Rani DS; Kanagasabai K; Lachyan A; Gawali P; Kapoor M; Chonker SK; Cutts FT; Sangal L; Mehendale SM; Sapkal GN; Gupta N; Hayford K; Moss WJ; Murhekar MV
Vaccine; 2023 Jan; 41(2):486-495. PubMed ID: 36481106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
